| Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach GD Anderson Clinical pharmacokinetics 44, 989-1008, 2005 | 782 | 2005 |
| Valproate therapy for prevention of posttraumatic seizures: a randomized trial NR Temkin, SS Dikmen, GD Anderson, AJ Wilensky, MD Holmes, ... Journal of neurosurgery 91 (4), 593-600, 1999 | 439 | 1999 |
| Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics GD Anderson Journal of women's health 14 (1), 19-29, 2005 | 421 | 2005 |
| St John's Wort: effect on CYP3A4 activity CA Roby, GD Anderson, E Kantor, DA Dryer, AH Burstein Clinical Pharmacology & Therapeutics 67 (5), 451-457, 2000 | 420 | 2000 |
| Gender differences in pharmacological response GD Anderson International review of neurobiology 83, 1-10, 2008 | 380 | 2008 |
| Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial NR Temkin, GD Anderson, HR Winn, RG Ellenbogen, GW Britz, ... The Lancet Neurology 6 (1), 29-38, 2007 | 374 | 2007 |
| A mechanistic approach to antiepileptic drug interactions GD Anderson Annals of Pharmacotherapy 32 (5), 554-563, 1998 | 308 | 1998 |
| Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections CH Goss, Y Kaneko, L Khuu, GD Anderson, S Ravishankar, ML Aitken, ... Science translational medicine 10 (460), eaat7520, 2018 | 258 | 2018 |
| An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers SE Airhart, LM Shireman, LJ Risler, GD Anderson, GA Nagana Gowda, ... PloS one 12 (12), e0186459, 2017 | 235 | 2017 |
| Children versus adults: pharmacokinetic and adverse‐effect differences GD Anderson Epilepsia 43, 53-59, 2002 | 225 | 2002 |
| Tramadol and seizures: a surveillance study in a managed care population JS Gardner, D Blough, CR Drinkard, D Shatin, G Anderson, D Graham, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (12 …, 2000 | 213 | 2000 |
| Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in l‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo JM Rho, GD Anderson, SD Donevan, HS White Epilepsia 43 (4), 358-361, 2002 | 206 | 2002 |
| The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases BT Ethell, GD Anderson, B Burchell Biochemical pharmacology 65 (9), 1441-1449, 2003 | 176 | 2003 |
| Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs GD Anderson Neurology 63 (10_suppl_4), S3-S8, 2004 | 171 | 2004 |
| Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products GD Anderson, LN Chan Clinical pharmacokinetics 55, 1353-1368, 2016 | 166 | 2016 |
| Bidirectional interaction of valproate and lamotrigine in healthy subjects GD Anderson, MK Yau, BE Gidal, SJ Harris, RH Levy, AA Lai, KB Wolf, ... Clinical Pharmacology & Therapeutics 60 (2), 145-156, 1996 | 164 | 1996 |
| Optimizing pediatric dosing: a developmental pharmacologic approach GD Anderson, AM Lynn Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (6 …, 2009 | 159 | 2009 |
| Neuropsychological effects of valproate in traumatic brain injury: a randomized trial SS Dikmen, JE Machamer, HR Winn, GD Anderson, NR Temkin Neurology 54 (4), 895-902, 2000 | 147 | 2000 |
| Comparison of the steady‐state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy WE Rosenfeld, S Liao, LD Kramer, G Anderson, M Palmer, RH Levy, ... Epilepsia 38 (3), 324-333, 1997 | 143 | 1997 |
| Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4‐ene‐valproate, a hepatotoxic metabolite of valproic acid RH Levy, AW Rettenmeier, GD Anderson, AJ Wilensky, PN Friel, ... Clinical Pharmacology & Therapeutics 48 (3), 225-235, 1990 | 143 | 1990 |
